does medicare cover any glp 1 drugs GLP-1 Medicare is now covering certain
Description
The first GLP-1 injectable receptor agonist exenatide was approved by the U.S
Annu Rev Pathol (2021) 16:299322
Diabetes 57 (Suppl
3.2kg, 2.8kg
Semaglutide represents the most widely studied GLP-1 agonist
Parenteral administration is expected to dominate the market, accounting for 80% of the market share in 2026, as GLP-1 Receptor Agonists are commonly administered via injections for better absorption and efficacy
